Phosphodiesterase 5 Inhibitor [EPC] — Patent Landscape
1
Drugs in class
4
Active US patents
73/100
Avg vulnerability
—
Annual revenue covered
Originators
Cliff calendar — next 15 years
4
38
Drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Cialis
tadalafil
|
Eli Lilly | 4 | 73 | — | 2038-12-24 |
Most attackable patents
Strongest defences
Related
- Phosphodiesterase 5 Inhibitor [EPC] class hub (all drugs incl. pipeline)
- AI Patent Landscape — type "phosphodiesterase 5 inhibitor" for an AI exec memo
- Company Patent Rankings